Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Mallinckrodt
Express Scripts
McKinsey
Boehringer Ingelheim

Last Updated: July 3, 2022

CLINICAL TRIALS PROFILE FOR TRIFERIC AVNU


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Triferic Avnu

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02595437 ↗ Triferic Pediatric Pharmacokinetic Protocol Completed Rockwell Medical Technologies, Inc. Phase 1/Phase 2 2015-11-01 The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered intravenously in pediatric patients with chronic kidney disease on chronic hemodialysis (CKD-5HD). It is an open-label, two-period sequential dosing study.
NCT02636049 ↗ Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers Completed Rockwell Medical Technologies, Inc. Phase 1 2015-10-01 This is a Phase 1, open-label, three-period sequential dosing study being conducted to determine the pharmacokinetics of Triferic iron administered intravenously (IV) to healthy adults.
NCT02739100 ↗ Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients Completed Rockwell Medical Technologies, Inc. Phase 1 2016-04-01 The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered via hemodialysate and via two different intravenous routes in adult patients with chronic kidney disease on chronic hemodialysis (CKD-5HD). It is an open-label, randomized single dose study.
NCT02767128 ↗ Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers Completed Rockwell Medical Technologies, Inc. Phase 1 2016-04-01 The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered orally in healthy adult volunteers. It is a randomized multiple treatments, single dose study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Triferic Avnu

Condition Name

Condition Name for Triferic Avnu
Intervention Trials
End Stage Renal Disease 8
Iron-Refractory Iron-Deficiency Anemia 1
Iron-refractory, Iron-deficiency Anemia (IRIDA) 1
Peritoneal Dialysis (PD) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Triferic Avnu
Intervention Trials
Kidney Failure, Chronic 8
Kidney Diseases 2
Anemia, Iron-Deficiency 2
Renal Insufficiency, Chronic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Triferic Avnu

Trials by Country

Trials by Country for Triferic Avnu
Location Trials
United States 22
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Triferic Avnu
Location Trials
Florida 5
Texas 3
Michigan 2
Ohio 2
Missouri 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Triferic Avnu

Clinical Trial Phase

Clinical Trial Phase for Triferic Avnu
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Triferic Avnu
Clinical Trial Phase Trials
Completed 9
Recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Triferic Avnu

Sponsor Name

Sponsor Name for Triferic Avnu
Sponsor Trials
Rockwell Medical Technologies, Inc. 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Triferic Avnu
Sponsor Trials
Industry 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Dow
Johnson and Johnson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.